Anti-LPA Recombinant Antibody scFv Fragment (LT3015 [B7(LT3000, Lpathomab)]) (CAT#: TAB-0340CL-S(P))
The high-affinity, specific monoclonal antibodies to LPA, one of which is also called Lpathpmab. The target of the antibody lysophosphatidic acid is a bioactive lipid mediating multiple cellular response, and it's involved in the establishment and progression of cancer by providing a pro-growth tumor microenvironment and promoting angiogenesis. By specifically react to LPA, the anti-LPA antbodies can be used in the treatment and prevention of malignancies, angiogenesis, and fibrosis-related disorders.
We specialize in custom recombinant antibody production, offering seamless execution from provided sequences to high-quality antibody deliverables, ensuring optimal yield and purity.
Figure 1 LPA binding affinity measured as in Figure for native LT3015 (WT) and three LT3015 single point mutations.
Fleming, J. K., Wojciak, J. M., Campbell, M. A., & Huxford, T. (2011). Biochemical and structural characterization of lysophosphatidic Acid binding by a humanized monoclonal antibody. Journal of molecular biology, 408(3), 462-476.
Figure 2 Site-directed mutagenesis and LPA binding assays of LT3015.
In comparison to native LT3015 (WT), the introduction of mutations in the LT3015 heavy chain (AsnH52Tyr/SerH52Tyr) or light chain (AnsL30Arg) does not significantly increase LPA affinity. However, their combination (AsnH52Tyr/SerH54Tyr/AsnL30Arg) results in a modified version of the antibody with increased LPA binding affinity.
Fleming, J. K., Wojciak, J. M., Campbell, M. A., & Huxford, T. (2011). Biochemical and structural characterization of lysophosphatidic Acid binding by a humanized monoclonal antibody. Journal of molecular biology, 408(3), 462-476.
Specifications
- Host Species
- Human
- Type
- Humanized Antibody
- Clone
- LT3015 [B7(LT3000, Lpathomab)]
- Related Disease
- Macular degeneration, pain-related disorders, malignancies, angiogenesis, fibrosis-related disorders
Target
- Alternative Names
- LPA; Lysophosphatidic acid
Product Notes
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Downloads
Download resources about recombinant antibody development and antibody engineering to boost your research.
See other products for "Clone LT3015 [B7(LT3000, Lpathomab)]"
See other products for "LPA"
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
PABL-329 | Recombinant Human Anti-S. aureus LPA Antibody | WB, ELISA, FuncS | IgG |
HPAB-0253-YC | Mouse Anti-LPA Recombinant Antibody (clone 2D1) | ELISA, WB | Mouse IgG |
HPAB-0254-YC | Mouse Anti-LPA Recombinant Antibody (clone B3) | ELISA, FuncS | Mouse IgG |
HPAB-0255-YC | Human Anti-LPA Recombinant Antibody (clone hB3) | ELISA, FuncS | Humanized IgG |
ZG-0295F | Mouse Anti-LPA Recombinant Antibody (ZG-0295F) | WB, IHC, ELISA | Mouse IgG |
Customer Reviews and Q&As
There are currently no Customer reviews or questions for TAB-0340CL-S(P). Click the button above to contact us or submit your feedback about this product.
Popular products with customers
Application: FC, IP, ELISA, Neut, FuncS, IF, IHC
Application: IP, IF, FuncS, FC, Neut, ELISA, ICC
Application: IF, IP, Neut, FuncS, ELISA, FC, ICC
Application: ELISA, FC, IP, FuncS, IF, Neut, ICC
Application: Block, Cyt, FuncS, Inhib
Application: WB, ELISA, FuncS
Application: FC, FuncS, IA, IF, IP, IHC
Application: WB, FC, IF, Inhib, ELISA, IHC
Application: ELISA, Inhib, FC, Neut
Application: ELISA, FC
For Research Use Only. Not For Clinical Use.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.